Banjarmasin, Indonesia – Authorities in Banjarmasin are intensifying surveillance efforts to combat a potential rise in measles cases, following reports of increased incidence in other regions of Indonesia. This heightened vigilance comes as public health officials emphasize the importance of vaccination as a key preventative measure against the highly contagious viral illness. While specific details regarding the recent increase in Banjarmasin are still emerging, the city government is proactively working to ensure adequate preparedness and response capabilities.
Measles, a highly contagious respiratory infection caused by the measles virus, can lead to serious complications, including pneumonia, encephalitis (brain swelling), and even death. The virus spreads through the air when an infected person coughs or sneezes. Symptoms typically begin with a fever, cough, runny nose, and red, watery eyes, followed by a rash that spreads over the body. Vaccination remains the most effective way to protect against measles.
Recent Developments and National Context
The increased attention to measles prevention in Banjarmasin aligns with a broader national effort to bolster immunization rates across Indonesia. In September 2018, it was reported that only 27 percent of children in Banjarmasin had received the Measles-Rubella (MR) vaccine, falling significantly short of the 90 percent target according to Antara News. This low coverage rate raised concerns among health officials about the potential for outbreaks. The initial MR immunization campaign in 2017 focused on six provinces in Java, with expansion to other regions, including Banjarmasin, planned for August and September 2018.
The initial rollout of the MR vaccine faced challenges, including hesitancy fueled by misinformation and religious concerns. In 2018, a fatwa (religious ruling) issued by the Indonesian Council of Islamic Scholars (MUI) regarding the MR vaccine, while ultimately affirming its permissibility, reportedly caused some public doubt due to concerns about the origin of certain vaccine components as reported by Antara News. Health authorities have since been working to address these concerns through public education campaigns emphasizing the vaccine’s safety and efficacy.
Banjarmasin’s Immunization Efforts: Past and Present
The Banjarmasin City Government initiated a large-scale immunization program in 2018, aiming to vaccinate 176,209 individuals against measles and rubella. The program targeted children aged 9 months to under 15 years, encompassing students from various educational institutions, including early childhood centers (PAUD), kindergartens (TK), elementary schools (SD/MI), special needs schools (SDLB), junior high schools (SMP/MTs), and special needs junior high schools (SMPLB) as detailed by Kumparan. Immunizations were planned to be administered both within schools and at designated immunization posts.
The success of the program hinged on collaboration between various stakeholders, including government agencies, healthcare professionals, and community organizations. Banjarmasin Mayor H Ibnu Sina stressed the importance of participation from all sectors of society to ensure the campaign’s effectiveness according to Kumparan. Specifically, the Mayor called upon the Departments of Education and Religious Affairs to provide data on target populations, issue supporting letters, and conduct outreach to parents.
The Role of Healthcare Professionals
The Banjarmasin City Government likewise sought the support of professional organizations, such as the Indonesian Pediatric Association (IDAI), the Indonesian Doctors Association (IDI), the Indonesian National Nurses Association (IBI), the Indonesian National Professional Nurses Association (PPNI), and the Indonesian Association of Private General Practitioners (PERSI), to promote the immunization campaign. These organizations were encouraged to disseminate information about the benefits of the MR vaccine and encourage community participation.
Understanding Measles and Rubella
Measles and rubella are both highly contagious viral diseases that can have serious consequences, particularly for young children and pregnant women. While measles primarily causes fever, rash, cough, and runny nose, it can lead to complications like pneumonia, encephalitis, and even death. Rubella, also known as German measles, is generally milder, but infection during pregnancy can cause severe birth defects.
The measles-rubella (MR) vaccine provides protection against both diseases with two doses. The World Health Organization (WHO) recommends that all countries strive to achieve and maintain at least 95% coverage with two doses of the MR vaccine to eliminate both measles and rubella.
Current Situation and Ongoing Concerns
While recent data specifically detailing the current measles situation in Banjarmasin is limited, the broader context of increasing measles cases globally and within Indonesia necessitates continued vigilance. The WHO has reported a significant increase in measles cases worldwide in 2024, largely attributed to declining vaccination rates. This global trend underscores the importance of maintaining high immunization coverage to prevent outbreaks and protect vulnerable populations.
As of March 11, 2026, reports indicate an increase in measles cases in the nearby region of Tabalong, Kalimantan, prompting health officials to urge residents to remain vigilant and ensure their children are vaccinated as reported on Instagram by Banjarmasin Terkini™. This serves as a reminder of the ongoing risk of measles transmission and the need for sustained immunization efforts.
Looking Ahead
The Banjarmasin City Government is expected to continue monitoring the measles situation closely and implementing appropriate public health measures to prevent outbreaks. This includes ongoing immunization campaigns, public education initiatives, and enhanced surveillance systems. The success of these efforts will depend on continued collaboration between government agencies, healthcare professionals, and the community.
The next key checkpoint for updates on the measles situation in Banjarmasin will be the release of the latest epidemiological data from the Kalimantan Selatan Provincial Health Office, expected in early April 2026. We encourage readers to stay informed about measles prevention and to consult with their healthcare providers regarding vaccination recommendations.
Have you or your family received the measles-rubella vaccine? Share your thoughts and experiences in the comments below. Please also share this article to help raise awareness about the importance of measles prevention.